Vyndaqel
Active substance: tafamidis meglumine
CAPSULE, LIQUID FILLED · TAFAMIDIS MEGLUMINE 20 mg/1
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TAFAMIDIS MEGLUMINE · 20 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12095-5fe2-79ac-9de5-2283eb32a040;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0069-1975
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0069-1975 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0069-1975 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0069-1975 · Verified 2026-10-09 · open in source